Intuitive Surgical ISRG
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Intuitive Surgical (ISRG) Core Market Data and Business Metrics
Latest Closing Price
$507.05Price-Earnings Ratio
78.98Total Outstanding Shares
358.28 Million SharesDividend
No dividendSIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
NASDAQHeadquarters
1020 Kifer Road, Sunnyvale, CA, 94086
Historical Stock Splits
If you bought 1 share of ISRG before July 1, 2003, you'd have 4.50 shares today.
| Execution Date | Split Amount |
|---|---|
| October 5, 2021 | 3-for-1 |
| October 6, 2017 | 3-for-1 |
| July 1, 2003 | 1-for-2 (Reverse Split) |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 3,084,196 Shares | 1.57 | 3/14/2025 | 4,846,639 Shares |
| 1,646,989 Shares | 2.93 | 2/28/2025 | 4,818,517 Shares |
| 1,237,425 Shares | 3.57 | 2/14/2025 | 4,412,034 Shares |
| 2,313,735 Shares | 1.82 | 1/31/2025 | 4,219,756 Shares |
| 1,582,769 Shares | 2.7 | 1/15/2025 | 4,272,941 Shares |
| 1,415,538 Shares | 3.11 | 12/31/2024 | 4,398,463 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $2.42 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-3.27 Billion |
| Net Cash Flow | $-707.70 Million |
| Net Cash Flow From Investing Activities | $-3.27 Billion |
| Exchange Gains/Losses | $-800,000 |
| Net Cash Flow From Financing Activities, Continuing | $150.90 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit, Deferred | $-135.30 Million |
| Costs And Expenses | $5.68 Billion |
| Net Income/Loss Attributable To Noncontrolling Interest | $14.90 Million |
| Operating Income/Loss | $2.35 Billion |
| Income Tax Expense/Benefit, Current | $471.60 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $2.32 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Parent | $2.28 Billion |
| Other Comprehensive Income/Loss Attributable To Noncontrolling Interest | $14.20 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $14.20 Million |
| Comprehensive Income/Loss | $2.30 Billion |
| Other Comprehensive Income/Loss | $-39.80 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Current Liabilities | $1.75 Billion |
| Liabilities And Equity | $18.74 Billion |
| Equity Attributable To Noncontrolling Interest | $95.90 Million |
| Equity | $16.53 Billion |
| Other Current Liabilities | $1.02 Billion |
| Inventory | $1.49 Billion |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||